DiaMedica Therapeutics Inc. (NASDAQ: DMAC) Stock Information | RedChip

DiaMedica Therapeutics Inc. (NASDAQ: DMAC)


$5.6350
-0.7750 ( -6.71% ) 115.7K

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

Market Data


Open


$5.6350

Previous close


$6.4100

Volume


115.7K

Market cap


$224.49M

Day range


$5.1850 - $6.1890

52 week range


$2.1400 - $6.4100

SEC Filings


Form Type Description Pages Date
8-k 8K-related 23 Nov 13, 2024
10-q Quarterly Reports 67 Nov 13, 2024
8-k 8K-related 16 Aug 07, 2024
10-q Quarterly Reports 63 Aug 07, 2024
4 Insider transactions 1 Jul 01, 2024
4 Insider transactions 1 Jul 01, 2024
8-k 8K-related 49 Jun 26, 2024
8-k 8K-related 18 Jun 26, 2024
4 Insider transactions 1 Jun 03, 2024
4 Insider transactions 1 Jun 03, 2024

Latest News